VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 733 filers reported holding VANECK VECTORS ETF TR in Q2 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,691,000 | -10.6% | 100,000 | 0.0% | 0.40% | +10.4% |
| Q2 2023 | $3,011,000 | -6.9% | 100,000 | 0.0% | 0.36% | -20.0% |
| Q1 2023 | $3,235,000 | -5.9% | 100,000 | -16.7% | 0.46% | -15.7% |
| Q4 2022 | $3,439,200 | +18.8% | 120,000 | 0.0% | 0.54% | +2.3% |
| Q3 2022 | $2,894,000 | -11.9% | 120,000 | 0.0% | 0.53% | -7.0% |
| Q2 2022 | $3,286,000 | -28.6% | 120,000 | 0.0% | 0.57% | -18.3% |
| Q1 2022 | $4,602,000 | +19.7% | 120,000 | 0.0% | 0.70% | -31.3% |
| Q4 2021 | $3,844,000 | +8.7% | 120,000 | 0.0% | 1.01% | +116.5% |
| Q3 2021 | $3,536,000 | -13.3% | 120,000 | 0.0% | 0.47% | -20.2% |
| Q2 2021 | $4,078,000 | +4.6% | 120,000 | 0.0% | 0.58% | -8.2% |
| Q1 2021 | $3,900,000 | -9.8% | 120,000 | 0.0% | 0.64% | -20.9% |
| Q4 2020 | $4,322,000 | – | 120,000 | – | 0.80% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |